2021 annual financial data
Artiva Biotherapeutics 2021 Operating margin
Direct answer
Operating margin was -2,660.94%.
Operating income was -53,272,000 USD and net income was -71,825,000 USD.
Operating cash flow was -15,304,000 USD.
Get free Artiva Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,002,000 USD
- Operating income
- -53,272,000 USD
- Net income
- -71,825,000 USD
- Operating cash flow
- -15,304,000 USD